Sepsis Diagnostics Market Poised for 8.5% CAGR Growth Through 2032 Amid Increased Adoption of Automa pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Marketresearch.biz reports that the Sepsis Diagnostics Market size is expected to be worth around USD 1.8 Bn by 2032 from USD 0.9 Bn in 2022, growing at a CAGR of 7.8% during the forecast period from 2023 to 2032.Overview of the Sepsis Diagnostics MarketThe Sepsis Diagnostics Market focuses on technologies and tests.
Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte® RAPID has received regulatory clearance by the Australian Therapeutic Goods Administration (TGA). The clearance of the company's flagship medical device by the regulatory body allows for the sale, use and further commercial testing of SeptiCyte RAPID throughout Australia to differentiate infection-positive (sepsis) from infection-negative systemic in
Sepsis Diagnostics Market to Surpass US$ 1,624.6 Million by 2030 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ According to Coherent Market Insights, Global Sepsis Diagnostics Market size was valued at US$ 841.4 Million in 2023 and is expected to surpass.